Results from a three-year trial suggest an experimental gene therapy for Huntington's disease can slow the progression of the deadly condition by 75%.
'Groundbreaking' gene therapy is first treatment for Huntington's disease to slow the condition
Live Science - 24 Sep 2025 17:39
Results from a three-year trial suggest an experimental gene therapy for Huntington's disease can slow the progression of the deadly condition by 75%.
Share this Article
Recommended